Skip to main content

Fate Therapeutics, Inc. - Common Stock (NQ: FATE )

1.615 -0.045 (-2.71%)
Streaming Delayed Price Updated: 9:43 AM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
January 11, 2016
Form 4
Source: SEC/Edgar
January 11, 2016
Form 4
Source: SEC/Edgar
January 11, 2016
Form 4
Source: SEC/Edgar
January 11, 2016
Form 4
Source: SEC/Edgar
October 15, 2015
Form 3
Source: SEC/Edgar
October 15, 2015
Form 4
Source: SEC/Edgar
October 15, 2015
Form 4
Source: SEC/Edgar
October 15, 2015
Form 4
Source: SEC/Edgar
October 15, 2015
Form 3
Source: SEC/Edgar
October 15, 2015
Form 4/A
Source: SEC/Edgar
May 17, 2015
Form 4
Source: SEC/Edgar
May 14, 2015
Form 4
Source: SEC/Edgar
May 14, 2015
Form 4
Source: SEC/Edgar
May 14, 2015
Form 4
Source: SEC/Edgar
May 14, 2015
Form 4
Source: SEC/Edgar
May 14, 2015
Form 4
Source: SEC/Edgar
May 14, 2015
Form 4
Source: SEC/Edgar
April 13, 2015
Form 4
Source: SEC/Edgar
April 13, 2015
Form 4
Source: SEC/Edgar
January 06, 2015
Form 4
Source: SEC/Edgar
January 06, 2015
Form 4
Source: SEC/Edgar
January 06, 2015
Form 4
Source: SEC/Edgar
January 06, 2015
Form 4
Source: SEC/Edgar
January 06, 2015
Form 4
Source: SEC/Edgar
June 11, 2014
Form 4
Source: SEC/Edgar
June 10, 2014
Form 4
Source: SEC/Edgar
June 09, 2014
Form 4
Source: SEC/Edgar
June 08, 2014
Form 4
Source: SEC/Edgar
June 08, 2014
Form 4
Source: SEC/Edgar
June 08, 2014
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.